resveratrol has been researched along with Pulmonary Embolism in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCreary, MR; Rhoda, DA; Schnell, PM | 1 |
| Hu, Z; Liu, X; Zhou, H | 1 |
| Duan, W; Huang, N; Jiang, Y; Li, W; Li, Y; Ren, B; Sun, J; Yang, K | 1 |
| Chan, C; Cheng, D; Chun, C; Dan, Y; Fangyou, Y; Honglei, X; Lehe, Y; Liangxing, W; Qi, Z; Weixi, Z; Xiaoying, H; Xueding, C; Yang, W; Yuanyuan, L; Zhoucang, Z | 1 |
1 trial(s) available for resveratrol and Pulmonary Embolism
| Article | Year |
|---|---|
Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19).
Topics: COVID-19 Drug Treatment; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Pulmonary Embolism; Resveratrol; SARS-CoV-2; Treatment Outcome | 2022 |
3 other study(ies) available for resveratrol and Pulmonary Embolism
| Article | Year |
|---|---|
Resveratrol attenuates chronic pulmonary embolism-related endothelial cell injury by modulating oxidative stress, inflammation, and autophagy.
Topics: Animals; Autophagy; Endothelial Cells; Humans; Hypertension, Pulmonary; Inflammation; Oxidative Stress; Pulmonary Artery; Pulmonary Embolism; Rats; Resveratrol; Thrombin | 2022 |
Resveratrol attenuates pulmonary embolism associated cardiac injury by suppressing activation of the inflammasome via the MALAT1‑miR‑22‑3p signaling pathway.
Topics: Animals; Apoptosis; Caspase 1; Cell Proliferation; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Heart Injuries; Humans; Inflammasomes; Interleukin-18; Interleukin-1beta; MicroRNAs; NLR Family, Pyrin Domain-Containing 3 Protein; Pulmonary Embolism; Rats; Resveratrol; RNA, Long Noncoding; Signal Transduction | 2019 |
Resveratrol downregulates acute pulmonary thromboembolism-induced pulmonary artery hypertension via p38 mitogen-activated protein kinase and monocyte chemoattractant protein-1 signaling in rats.
Topics: Animals; Blotting, Western; Chemokine CCL2; Down-Regulation; Enzyme Inhibitors; Fluorescent Antibody Technique; Hypertension, Pulmonary; Imidazoles; Immunohistochemistry; Indicators and Reagents; Male; p38 Mitogen-Activated Protein Kinases; Pulmonary Embolism; Pyridines; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes | 2012 |